Quell Therapeutics Limited

Projekt → Advanced Engineering of Nitric Oxide Based Therapeutics for Triple Negative Breast Cancer Training Network NO-CANCER-NET will focus on Triple Negative Breast Cancer (TNBC) and Nitric Oxide (NO)-related therapeutic development. TNBC acco… Beitrag ansehen → Unternehmen → ACCESSION THERAPEUTICS LIMITED Beitrag ansehen → Projekt → Backbone-Optimized OligonucleotideS for Therapeutics Therapeutic oligonucleotides (ONs) have recently gained increasing importance as new drugs. While conventional drugs are limited… Beitrag ansehen → Projekt → Synthetic Chimeric Antigen Receptors: Hijacking Nitrenium Ions for Targeting, Therapy and Safety of Next Generation T Cell Therapy Chimeric antigen receptor (CAR) T cell therapy is a promising approach for cancer treatment with remarkable clinical outcomes. CA… Beitrag ansehen → Projekt → Künstliche Intelligenz im bildungspolitischen Diskurs Der Beitrag untersucht, wie sogenannte Künstliche Intelligenz (KI) im Bildungskontext durch metaphorische Sprachmuster beschriebe… Beitrag ansehen → Projekt → Multi-Omics Integration for Drug Therapy Optimization Precision therapeutics is a growing recognition of drug response as governed by complex layer-based biological systems and not ju… Beitrag ansehen →